Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
As technology continues to evolve, the trajectory for MIS in ASCs remains positive. With continued innovation, procedural migration, and improved patient selection, the next decade is poised to bring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback